SPECIAL ISSUE | Dr. Suzie Robertson
REDEFINING THE MATRIX: HOW DR. SUZIE ROBERTSON AND HER TEAM ARE ENGINEERING FOR THE FUTURE OF REGENERATIVE MEDICINE PG 34
REDEFINING THE
MATRIX
How Dr. Suzie Robertson Is Engineering the Future of Regenerative Medicine Written by Riley George Medicine is entering a new era — one in which the goal is no longer simply to treat disease, but to restore function, regenerate tissue, and reimagine the healthy lifespan and limits of the human body. However, revolutionary therapies alone do not transform medicine. What truly changes healthcare is infrastructure: the systems, safety frameworks, technologies, and data intelligence that propel innovation from isolated breakthroughs into scalable clinical practice. Few leaders understand this distinction better than Dr. Suzie Robertson, Pharm.D., founder and CEO of Matrix Biologics. While many pioneers in regenerative medicine are focused on the therapies themselves, Dr. Robertson has taken on a far more ambitious challenge: building the operational and technological architecture that will allow regenerative medicine to mature into a trusted, scalable discipline within modern healthcare. Through Matrix Biologics, Dr. Robertson and her executive leadership team are building an integrated ecosystem that unites biological innovation, clinical safety systems, and provider enablement platforms. Central to this vision is developing and deploying a platform designed to bring data-driven intelligence, safety guardrails, and scalable clinical precision to regenerative
“Medical breakthroughs change what is possible — but it is infrastructure, safety, and data that determine whether those breakthroughs can truly change the world.” — Dr. Suzie Robertson
medicine. Their goal is not simply to participate in the regenerative medicine revolution; it is to establish a robust foundation that enables regenerative medicine to advance responsibly into broad, mainstream clinical adoption.
A Career Built on Safety, Systems, and Clinical Integrity Dr. Robertson’s perspective on regenerative medicine is shaped by more than two decades inside one of healthcare’s most disciplined environments: hospital pharmacy. Throughout her career as a clinical pharmacist, compliance officer, medication safety leader, and clinical informaticist, Dr. Robertson has led the development of advanced systems and safety frameworks designed to prevent medical errors and safeguard patient lives. She leads the design of clinical protocols, implements rigorous compliance frameworks, and deploys cutting-edge health information technologies that enable physicians to make safer, datadriven decisions. Regenerative medicine inspired her to investigate how cutting-edge science could transform patient outcomes. What she discovered was both exciting and concerning. “Regenerative therapies have enormous potential to support the body’s natural healing processes,” Dr. Robertson explained. “But the industry lacks the infrastructure that modern healthcare depends on — standardized protocols, safety intelligence, and measurable outcomes.” These experiences revealed a critical truth: if regenerative therapies were to reach patients responsibly, the industry needed structure, oversight, and measurable outcomes. That insight became the guiding vision behind the founding of Matrix Biologics. Rather than simply distributing regenerative solutions, Dr. Robertson set out to build something far more ambitious: a technology-enabled provider ecosystem designed to support the widespread adoption of regenerative medicine.
When Personal Experience Meets Scientific Opportunity For Dr. Robertson, the decision to pursue this mission was not purely professional — it was also deeply personal. Her husband, a Marine veteran, had endured debilitating back pain for more than two decades. Despite access to top specialists, surgical consultations, and a long list of conventional treatments, his quality of life continued to deteriorate.
One day, she found him collapsed on the floor, unable to move. “We were in our early 40s, and we were forced to ask ourselves what the next 30 years of our lives were going to look like,” she said. After extensive research, Dr. Robertson pursued regenerative therapy using exosome-based biologics. The results were remarkable. Within weeks, her husband, who had been immobilized, was back in the pool playing with their four daughters. Five years later, he continues to enjoy a full recovery. A second experience soon followed. A close friend was suffering severe respiratory complications from long-haul COVID. After months of emergency room visits and consultations with multiple specialists, his symptoms continued to worsen. That’s when Dr. Robertson stepped in and brought him to Scottsdale for regenerative therapy. Less than 24 hours later, he reported that his symptoms had disappeared. “The experience made one thing crystal clear: regenerative therapies can only reach patients safely and effectively when the industry is built on rigorous structure, oversight, and measurable outcomes,” Dr. Robertson said. That insight became the blueprint for Matrix Biologics: How can we change lives, change outcomes?
Building the Operating System for Regenerative Medicine Matrix Biologics was founded on a single principle: Innovation without safety and infrastructure cannot transform healthcare. To address this challenge, Matrix Biologics developed a comprehensive platform that enables healthcare providers to implement regenerative medicine programs within existing clinical workflows. The platform integrates: • Product access • Certified patient education and engagement tools • Accredited physician training and continuing medical education • Clinical program implementation within existing workflows • Electronic data capture and longitudinal patient monitoring
• Real-world outcomes analysis and safety reporting The result is a new operational model for regenerative medicine that emphasizes clinical excellence, transparency, and continuous learning while empowering providers and distribution partners to expand responsibly. “Our goal is to empower providers to deliver regenerative therapy safely and effectively, while upholding the highest standards of oversight and patient safety,” Dr. Robertson said.
Where Biology Meets Intelligence A defining feature of Matrix Biologics’ platform is the integration of technologies designed specifically for regenerative medicine. The platform serves as a digital co-pilot for physicians, interpreting imaging, guiding patient evaluations, and analyzing treatment outcomes across a growing network of providers. By aggregating real-world clinical data, the system empowers physicians to identify patterns and refine protocols in ways that were previously impossible.
Leading the Next Era of Medicine As regenerative medicine continues to expand, she cautions that the field’s rapid growth must be accompanied by greater transparency and accountability. Her extensive background in pharmacy, compliance, clinical informatics, and patient safety makes her particularly vocal about the need for standardized dosing, validated sourcing, and measurable outcomes. “How can we be certain of the sourcing and potency of every manufacturer?” she proposed. “If providers don’t have clear measurement and real-world data, they’re essentially practicing in the dark.” We’ve taken the guesswork out of the process by thoroughly vetting the sources behind every product we distribute, so our providers can feel confident they are receiving Matrixcertified products.
Engineering the Future of Regenerative Healthcare
Robertson describes this convergence as the intersection of biology and intelligence, ultimately changing outcomes.
For Dr. Robertson, the transformation of regenerative medicine is not simply about new treatments. It is about building the systems that allow those treatments to reach patients safely and responsibly.
“Biology restores and data redefines,” she said. “When you combine regenerative science with advanced analytics, you create the safety guardrails and outcome visibility that modern healthcare requires.”
Through Matrix Biologics, they are engineering the infrastructure that will allow regenerative medicine to mature into a trusted, scalable medical discipline — poised to be fully integrated into mainstream medicine. Dr. Lauren Beardsley, NMD, is the Chief Medical Officer for
Matrix Biologics and possesses an intimate understanding of the fragility inherent to the biologics landscape, having navigated the largely unregulated frontier of regenerative medicine for nearly two decades. Under her leadership, Matrix Biologics has built its reputation at the intersection of heart and precision—pairing a genuine commitment to patient outcomes with the kind of data-driven rigor and safety biologics distribution demands.
Within the healthcare ecosystem, Dr. Robertson and her team are reimagining modern medicine; regenerative medicine is no longer a fragmented frontier. It will be a structured, datadriven platform for the future of medicine.
By bringing together biological innovation, data analytics, and clinical safety frameworks, Matrix Biologics is reshaping how regenerative treatments are delivered, studied, and ultimately adopted across modern healthcare.
To learn more about Matrix Biologics and their mission to improve patient outcomes while advancing the future of regenerative medicine, visit MatrixBiologics.com.
“The future of medicine belongs to leaders who combine science, compliance, data, and heart,” Dr. Suzie Robertson concluded.
“Every healthcare provider wants the same thing—to help more patients heal and improve their quality of life. Our role at Matrix Biologics is to equip providers with the trusted solutions, education, and support they need to deliver exceptional care with confidence.” — Dr. Lauren Beardsley, NMD, Chief Medical Officer
introduces a fully integrated platform combining accredited biologic sourcing with data-driven precision tools.
ACCREDITED BIOLOGIC SOURCING
matrixbiologics.com
FDA-REGISTERED DISTRIBUTION
|
DATA-DRIVEN PRECISION
info@matrixbiologics.com
|
EMPOWERS PROVIDERS
(602) 480-0486